References
Derdeyn CP, Zipfel GJ, Albuquerque FC, Cooke DL, Feldmann E, Sheehan JP, Torner JC, Council American Heart Association Stroke (2017) Management of Brain Arteriovenous Malformations: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48(8):e200–e224
Kim H, Al-Shahi Salman R, McCulloch CE, Stapf C, Young WL, Coinvestigators MARS (2014) Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology 83:590–597
Gross BA, Du R (2013) Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg 118:437–443
Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier C, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld J, Klijn CJ, Harkness K, Libman R, Barreau X, Moskowitz AJ, International ARUBA Investigators (2014) Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 383:614–621
Darsaut TE, Magro E, Gentric JC, Batista AL, Chaalala C, Roberge D, Bojanowski MW, Weill A, Roy D, Raymond J (2015) Treatment of brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial. Trials 16:497
Jabbari E, Sethuraman S, Sekaran L (2014) The clinical dilemma of treating transient ischaemic attack-like symptoms in patients with coexisting arteriovenous malformation. BMJ Case Rep 15:19. https://doi.org/10.1136/bcr-2013-201315
Ricci S, Pistoia F, Carolei A, Sacco S (2015) Restarting oral anticoagulants after intracerebral hemorrhage: cons. Intern Emerg Med 10:5–7
Birocchi S, Podda GM, GrAM (Gruppo di Auto formazione Metodologica) (2017) Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhage. Intern Emerg Med 12(4):527–529
Sturiale CL, Pignotti F, Giordano M, Porfidia A, Albanese A, Giarretta I, Puca A, Gaetani E, Darrigo S, Truma A, Olivi A, Pola R, Sporadic AVMs-HHT Study Group (2018) Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study. Intern Emerg Med. https://doi.org/10.1007/s11739-018-1918-7
Langer DJ, Lasner TM, Hurst RW, Flamm ES, Zager EL, King JT Jr (1998) Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery 42(3):481–486
Hasan DM, Mahaney KB, Brown RD Jr, Meissner I, Piepgras DG, Huston J, Capuano AW, Torner JC, International Study of Unruptured Intracranial Aneurysms Investigators (2011) Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 42(11):3156–3162
Schneble HM, Soumare A, Hervé D, Bresson D, Guichard JP, Riant F, Tournier-Lasserve E, Tzourio C, Chabriat H, Stapf C (2012) Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke 43(12):3196–3199
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author(s) declare that they have no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
None.
Rights and permissions
About this article
Cite this article
Tiseo, C., Carolei, A. Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study. Intern Emerg Med 13, 1181–1183 (2018). https://doi.org/10.1007/s11739-018-1978-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-018-1978-8